Financial Statements · Financial Reporting
AstraZeneca Eesti OÜ
Official identifier 11733875Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 19 Jun 2025
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 4,922,264 |
| Balance sheet | Cash and cash equivalents | 2,933,188 |
| Balance sheet | Current assets | 4,906,842 |
| Balance sheet | Current liabilities | 1,597,430 |
| Balance sheet | Equity | 3,324,834 |
| Balance sheet | Share capital at nominal value | 690,246 |
| Balance sheet | Non-current assets | 15,422 |
| Balance sheet | Retained earnings (loss) from previous periods | 2,259,279 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -2,755 |
| Income statement scheme 1 | Labour costs | -4,395,114 |
| Income statement scheme 1 | Revenue | 6,287,586 |
| Income statement scheme 1 | Annual period profit / loss | 306,284 |
| Income statement scheme 1 | Operating profit (loss) | 304,679 |
| Income statement scheme 1 | Profit (loss) before income tax | 306,284 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 2,259,279 |
| Note: Labour costs | Employees | 41 |
| Note: Labour costs | Labour costs | 4,395,114 |
Linked company
Company: AstraZeneca Eesti OÜ